Nuclear medicine imaging of multiple myeloma, particularly in the relapsed setting
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Nuclear medicine imaging of multiple myeloma, particularly in the relapsed setting ; volume:44 ; number:2 ; day:29 ; month:11 ; year:2016 ; pages:332-341 ; date:2.2017
European journal of nuclear medicine and molecular imaging ; 44, Heft 2 (29.11.2016), 332-341, 2.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Waal, Esther G. M. de
- Beteiligte Personen und Organisationen
-
Glaudemans, Andor W. J. M.
Schröder, Carolien P.
VELLENGA, EDO
Slart, Riemer H. J. A.
SpringerLink (Online service)
- DOI
-
10.1007/s00259-016-3576-1
- URN
-
urn:nbn:de:1111-201701315046
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 08:44 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Waal, Esther G. M. de
- Glaudemans, Andor W. J. M.
- Schröder, Carolien P.
- VELLENGA, EDO
- Slart, Riemer H. J. A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Accelerated single cell seeding in relapsed multiple myeloma
Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed Setting
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
Daratumumab Plus Carfilzomib: An Optimistic Approach in Relapsed/Refractory Multiple Myeloma
Successful Usage of External Beam Radiation to Myeloma Cutaneous Lesions in Patient with Refractory, Relapsed Multiple Myeloma
Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma
Accelerated single cell seeding in relapsed multiple myeloma
Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed Setting
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
Daratumumab Plus Carfilzomib: An Optimistic Approach in Relapsed/Refractory Multiple Myeloma
Successful Usage of External Beam Radiation to Myeloma Cutaneous Lesions in Patient with Refractory, Relapsed Multiple Myeloma
Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma
Accelerated single cell seeding in relapsed multiple myeloma
Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed Setting
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Updated Perspectives on the Management of Relapsed and Refractory Multiple Myeloma
Daratumumab Plus Carfilzomib: An Optimistic Approach in Relapsed/Refractory Multiple Myeloma
Successful Usage of External Beam Radiation to Myeloma Cutaneous Lesions in Patient with Refractory, Relapsed Multiple Myeloma